search
Back to results

Continuous Glucose Monitors for Children With Diabetes Mellitus

Primary Purpose

Diabetes Mellitus, Insulin-Dependent

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
The GlucoWatch® G2™ Biographer (GW2B)
The Continuous Glucose Monitoring System (CGMS™)
Sponsored by
Jaeb Center for Health Research
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus, Insulin-Dependent focused on measuring Diabetes Mellitus, Insulin-Dependent, Type 1 Diabetes, Diabetes in Children, Continuous Glucose Monitoring Devices

Eligibility Criteria

1 Year - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria Clinical diagnosis of type 1 diabetes mellitus for at least 1 year prior to study entry For children over 2 years of age, body mass index between the 5th and 95th percentile for age and gender Weight >= 12 kg (26.5 lbs) if < 7 years of age and >= 16 kg (35 lbs) if >7 years of age Normal hematocrit Exclusion Criteria Current use of glucocorticoids Skin or other medical disorders that would affect completion of the study History of seizures other than those attributable to either hypoglycemia or high fever

Sites / Locations

  • Division of Pediatric Endocrinology and Diabetes, Stanford University
  • Barbara Davis Center for Childhood Diabetes, University of Colorado
  • Department of Pediatrics, Yale University School of Medicine
  • Nemours Children's Clinic
  • Jaeb Center for Health Research
  • Department of Pediatrics, University of Iowa Carver College of Medicine

Outcomes

Primary Outcome Measures

Accuracy of the GlucoWatch G2 Biographer and CGMS

Secondary Outcome Measures

Full Information

First Posted
September 29, 2003
Last Updated
September 2, 2016
Sponsor
Jaeb Center for Health Research
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
search

1. Study Identification

Unique Protocol Identification Number
NCT00069537
Brief Title
Continuous Glucose Monitors for Children With Diabetes Mellitus
Official Title
DirecNet Inpatient Study to Test the Accuracy of Continuous Blood Glucose Monitoring Devices in Children With Type 1 Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
September 2016
Overall Recruitment Status
Completed
Study Start Date
May 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
November 2002 (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Jaeb Center for Health Research
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

4. Oversight

5. Study Description

Brief Summary
Good control of blood glucose levels is important in preventing complications from diabetes. This study assessed the accuracy and reliability of two FDA-approved continuous glucose monitors, the Continuous Glucose Monitoring System (CGMS) and the GlucoWatch G2 Biographer (GW2B), in children with type 1 diabetes mellitus (T1DM).
Detailed Description
Intensive control of blood glucose levels has been shown to substantially prevent or delay complications of T1DM in adolescents and adults. The major limitation to implementation of intensive glycemic control is hypoglycemia. Younger children may be at increased risk for hypoglycemia and the risk/benefit ratio of intensive glycemic control may be less favorable in this population. Intensive therapy has not been systematically evaluated in children less than 13 years of age. This study was conducted by the Diabetes Research in Children Network (DirecNet) to assess the accuracy of the CGMS and the GW2B glucose monitors in comparison with standard blood glucose measurements in an inpatient setting. During 24-hour clinical research center stays at five clinical centers, approximately 90 children and adolescents with T1DM (1 to 17 years of age) wore two FDA-approved continuous glucose monitors, CGMS and GW2B, and had frequent serum glucose determinations during the day and night. To assess glucose monitor function during periods of rising and falling blood glucose, insulin-induced hypoglycemia and meal-induced hyperglycemia tests were also performed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Insulin-Dependent
Keywords
Diabetes Mellitus, Insulin-Dependent, Type 1 Diabetes, Diabetes in Children, Continuous Glucose Monitoring Devices

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
90 (false)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
The GlucoWatch® G2™ Biographer (GW2B)
Intervention Type
Device
Intervention Name(s)
The Continuous Glucose Monitoring System (CGMS™)
Primary Outcome Measure Information:
Title
Accuracy of the GlucoWatch G2 Biographer and CGMS

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria Clinical diagnosis of type 1 diabetes mellitus for at least 1 year prior to study entry For children over 2 years of age, body mass index between the 5th and 95th percentile for age and gender Weight >= 12 kg (26.5 lbs) if < 7 years of age and >= 16 kg (35 lbs) if >7 years of age Normal hematocrit Exclusion Criteria Current use of glucocorticoids Skin or other medical disorders that would affect completion of the study History of seizures other than those attributable to either hypoglycemia or high fever
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
William V. Tamborlane, MD
Organizational Affiliation
Yale University
Official's Role
Study Chair
Facility Information:
Facility Name
Division of Pediatric Endocrinology and Diabetes, Stanford University
City
Stanford
State/Province
California
ZIP/Postal Code
94305-5208
Country
United States
Facility Name
Barbara Davis Center for Childhood Diabetes, University of Colorado
City
Denver
State/Province
Colorado
ZIP/Postal Code
80262
Country
United States
Facility Name
Department of Pediatrics, Yale University School of Medicine
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06519
Country
United States
Facility Name
Nemours Children's Clinic
City
Jacksonville,
State/Province
Florida
ZIP/Postal Code
32207
Country
United States
Facility Name
Jaeb Center for Health Research
City
Tampa
State/Province
Florida
ZIP/Postal Code
33647
Country
United States
Facility Name
Department of Pediatrics, University of Iowa Carver College of Medicine
City
Iowa City
State/Province
Iowa
ZIP/Postal Code
52242
Country
United States

12. IPD Sharing Statement

Citations:
Citation
Mauras N, Beck R, Ruedy K, Booth A, Weinzimer S, and the Diabetes Research in Children Network (DirecNet) Study Group. The Physiological Variations of Plasma Glucose Concentrations in Healthy, Non-Diabetic Children: Use of Continuous Glucose Sensors. Pediatr Res 2003 Apr;53(4Pt 2):1A-669A
Results Reference
background
Citation
Weinzimer S, Beck R, Ruedy K, Booth A, Boland E, and the Diabetes Research in Children Network (DirecNet) Study Group. Mealtime Glycemic Excursions in Pediatric Subjects with Type 1 Diabetes Mellitus (T1DM): The DirecNet Experience.Pediatr Res 2003 Apr;53(4Pt2):1A-669A
Results Reference
background
Citation
Tsalikian E, Beck R, Ruedy K, Booth A, Tansey M, and the Diabetes Research in Children Network (DirecNet) Study Group. Glycemic Pattern of Insulin Induced Hypoglycemia in Pediatric Subjects with Type 1 Diabetes Mellitus (T1DM): The DirecNet Experience. Pediatr Res 2003 Apr;53(4Pt2):1A-669A
Results Reference
background
Citation
Buckingham B, Beck R, Tamborlane W, Ruedy K, Boland E, Chase P, Wysocki T, Tsalikian E, Wilson D, Mauras N, Weinzimer D, Tansey M, Fiallo-Scharer R, Booth A, Kollman C, and the Diabetes Research In Children Network (DirecNet) Study Group. Diabetes Research in Children Network (DirecNet) Accuracy Study of the Continuous Glucose Monitoring System (CGMS) and GlucoWatch® G2™ Biographer (GWB) in Children with Type 1 Diabetes-A CRC-based Study. Diabetes 2003 Jun;52 Suppl 1:A36.
Results Reference
background
Citation
Wilson D, Buckingham B, Beck R, Ruedy K, Kollman C, Tsalikian E, Wysocki T, Weinzimer S, Chase P, and the Diabetes Research in Children Network (DirecNet) Study Group. A 5-center CRC-based Study of the Accuracy of the GlucoWatch®G2™ Biographer in Children and Adolescents with Type 1 Diabetes. Diabetes 2003 Jun;52 Suppl 1:A101.
Results Reference
background
Citation
Boland E, Weinzimer S, Beck R, Ruedy K, Kollman C, Buckingham B, Chase P, Tansey M, Mauras N, and the Diabetes Research In Children Network (DirecNet) Study Group. Performance of the Medtronic MiniMed Continuous Glucose Monitoring System (CGMS) in Children with T1DM in the DirecNet Accuracy Study. Diabetes 2003 Jun;52 Suppl 1:A90.
Results Reference
background
Citation
Fiallo-Scharer R, Chase P, Beck R, Ruedy K, Booth A, Wysocki T, Boland E, Buckingham B, Tsalikian E, and the Diabetes Research In Children Network (DirecNet) Study Group. Performance of the One Touch Ultra at Different Glucose Levels in Three Age Groups of Children with T1DM in the CRC-DirecNet Accuracy Study. Diabetes 2003 Jun;52 Suppl 1:A562.
Results Reference
background
PubMed Identifier
14633344
Citation
Diabetes Research in Children Network (DIRECNET) Study Group. The accuracy of the GlucoWatch G2 biographer in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther. 2003;5(5):791-800. doi: 10.1089/152091503322526996.
Results Reference
background
PubMed Identifier
14633343
Citation
Diabetes Research in Children Network (DIRECNET) Study Group. The accuracy of the CGMS in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther. 2003;5(5):781-9. doi: 10.1089/152091503322526987.
Results Reference
background
PubMed Identifier
14709195
Citation
Diabetes Research In Children Network (Direcnet) Study Group. A multicenter study of the accuracy of the One Touch Ultra home glucose meter in children with type 1 diabetes. Diabetes Technol Ther. 2003;5(6):933-41. doi: 10.1089/152091503322640971.
Results Reference
background
PubMed Identifier
14988292
Citation
Diabetes Research in Children Network (DirecNet) Study Group. Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: experience of the Diabetes Research in Children Network. Diabetes Care. 2004 Mar;27(3):722-6. doi: 10.2337/diacare.27.3.722.
Results Reference
background
PubMed Identifier
15628809
Citation
Tsalikian E, Kollman C, Mauras N, Weinzimer S, Buckingham B, Xing D, Beck R, Ruedy K, Tamborlane W, Fiallo-Scharer R; Diabetes Research in Children Network (DirecNet) Study Group. GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children. Diabetes Technol Ther. 2004 Oct;6(5):559-66. doi: 10.1089/dia.2004.6.559.
Results Reference
background
PubMed Identifier
15738721
Citation
Tsalikian E, Beck RW, Kalajian A, Janz KF, Tansey MJ; Diabetes Research in Children Network (DirecNet) Study Group. Function of the GlucoWatch G2 Biographer during exercise. Diabetes Technol Ther. 2005 Feb;7(1):230. doi: 10.1089/dia.2005.7.230. No abstract available.
Results Reference
background
PubMed Identifier
15929675
Citation
Buckingham B, Block J, Burdick J, Kalajian A, Kollman C, Choy M, Wilson DM, Chase P; Diabetes Research in Children Network. Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol Ther. 2005 Jun;7(3):440-7. doi: 10.1089/dia.2005.7.440.
Results Reference
background

Learn more about this trial

Continuous Glucose Monitors for Children With Diabetes Mellitus

We'll reach out to this number within 24 hrs